Targeting one-carbon metabolic vulnerabilities of metastasis with therapeutic potential

Area of Science:

• Oncology
• Molecular Biology
• Metabolic Pathways

Background:

• Tumor progression is linked to increased cellular autonomy and complex signaling networks.
• The specific signaling pathways driving cancer metastasis remain largely undefined.
• Understanding these pathways is crucial for developing effective anti-metastatic therapies.

Purpose of the Study:

• To identify key metabolism pathways and genes involved in inhibiting tumor metastasis.
• To investigate the role of specific metabolic pathways in cancer cell colonization of distant sites.
• To discover novel compounds capable of blocking tumor metastasis by targeting these metabolic pathways.

Main Methods:

• Utilized metastatic functional screening to identify relevant metabolic pathways and genes.
• Engineered cancer cells with varying metastatic potential to validate metabolic pathway functions.
• Tested known inhibitors and identified novel compounds targeting identified genes and pathways.

Main Results:

• Identified one-carbon and SSP metabolism pathways as critical regulators of tumor metastasis inhibition.
• Confirmed the role of these metabolism pathways in controlling cancer cell colonization across different tissues.
• Discovered three novel compounds that inhibit gene expression and block tumor metastasis.

Conclusions:

• Tumor cells reprogram metabolism to enhance migration, invasion, and survival during metastasis.
• The identified metabolic pathways and genes offer promising therapeutic targets for metastatic disease.
• The novel compounds provide a rational strategy for guiding clinical treatment of metastatic cancers.